Feinberg to leave Google Health for Cerner – STAT – STAT

Feinberg To Leave Google Health For Cerner Stat Stat
Feinberg To Leave Google Health For Cerner Stat Stat

David Feinberg has left his post as the leader of Google Health for health care record giant Cerner Corporation after just over two years on the job. Feinberg, a health care veteran with a history of overseeing hospital systems including UCLA Health and Pennsylvania-based Geisinger, is joining Cerner as president and chief executive officer on Oct. 1.

As Google Health’s first vice president, Feinberg oversaw the company’s far-reaching international health efforts — which spanned initiatives at Alphabet life science spinout Verily, artificial intelligence company DeepMind, and Google Health, among others. Under his tenure, Google acquired Fitbit, signed and expanded a controversial pilot project with hospital chain Ascension using patient data, launched a research app to let Android users participate in health studies, and oversaw early work on patient health records

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.